FluoGuide has completed a directed share issue raising approximately SEK 25 million
Copenhagen, Denmark, 10 March 2022 – FluoGuide A/S (publ) a developer of surgical precision solutions within oncology (“FluoGuide” or the “Company”) (Nasdaq First North Growth Market: FLUO) hereby announces that the Company has successfully completed a directed share issue raising approximately SEK 25 million in gross proceeds (the “Directed Share Issue”). The Directed Share Issue was subscribed by a number of Swedish and international institutional investors, which included, among others A/S Arbejdernes Landsbank, Linc AB, OP Fund Management-Nordic Micro Cap Fund and Eastbridge.The board